130 related articles for article (PubMed ID: 4408136)
1. [The pharmacology of glisoxepide, a new oral antidiabetic].
Puls W; Losert W; Loge O; Schillinger E; Keup U; Kroneberg G
Arzneimittelforschung; 1974 Mar; 24(0):375-92. PubMed ID: 4408136
[No Abstract] [Full Text] [Related]
2. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
Tettenborn D
Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
[No Abstract] [Full Text] [Related]
3. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
4. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
Loubatières AL; Ribes G; Loubatières-Mariani MM
C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
[No Abstract] [Full Text] [Related]
5. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
6. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
Birk W; Petrides P
Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
[No Abstract] [Full Text] [Related]
7. [Pharmacokinetics of radioactively labeled glisoxepide in the animal].
Kolb KH; Schulze PE; Speck U; Acksteiner B
Arzneimittelforschung; 1974 Mar; 24(0):397-403. PubMed ID: 4211553
[No Abstract] [Full Text] [Related]
8. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
Duhault J; Boulanger M; Tisserand F; Bergi L
Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
[No Abstract] [Full Text] [Related]
9. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
[No Abstract] [Full Text] [Related]
10. [Protein binding of glisoxepide and its influence on the protein binding of phenprocoumon].
Schlossmann K
Arzneimittelforschung; 1974 Mar; 24(0):392-7. PubMed ID: 4408096
[No Abstract] [Full Text] [Related]
11. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
12. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
13. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
14. [Pharmacodynamics and studies on the mechanism of action of HB 419].
Schmidt FH; Stork H; Bänder A; Pfaff W
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1369-73. PubMed ID: 5394455
[No Abstract] [Full Text] [Related]
15. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
Beyer J; Cordes U; Sell G; Krall H; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
[No Abstract] [Full Text] [Related]
16. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
17. Insulinotropic action of a new sulfonylurea: gliclazide.
Malaisse WJ; Leclercq-Meyer V
Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
[No Abstract] [Full Text] [Related]
18. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].
Schöffling K; Haupt E; Köberich W; Beyer J
Klin Wochenschr; 1973 Jan; 51(2):68-77. PubMed ID: 4631325
[No Abstract] [Full Text] [Related]
19. [Mode of action of oral antidiabetic drugs].
Frey H
Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
[No Abstract] [Full Text] [Related]
20. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
